KR
Kristian Reich
Chief Scientific Officer

Kristian Reich insider trades: MoonLake Immunotherapeutics (MLTX) stock sales

Chief Scientific Officer, MoonLake Immunotherapeutics Last trade Jul 22, 2026 15 Form 4 filings
$8.1M
Sold, last 12 months
5 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2024
1
Company
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Kristian reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jul 22, 2026MLTX↓ Sell$1.0M
Jul 20, 2026MLTX↓ Sell$878K
Jul 15, 2026MLTX↓ Sell$322K
Jun 17, 2026MLTX↓ Sell$2.9M
Dec 9, 2025MLTX↓ Sell$3.0M
Feb 28, 2024MLTX↓ Sell$3.4M
Feb 28, 2024MLTX↓ Sell$3.2M
Feb 21, 2024MLTX↓ Sell$606K
Feb 21, 2024MLTX↓ Sell$603K
Feb 16, 2024MLTX↓ Sell$1.8M
Feb 16, 2024MLTX↓ Sell$1.8M

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MLTX insiders

Open-market trades in the last 12 months

About Kristian Reich's insider trades

Kristian Reich is Chief Scientific Officer at MoonLake Immunotherapeutics (MLTX). Since Feb 16, 2024, Kristian has reported no open-market purchases and 11 sales worth $19.5M on SEC Form 4. In the last 12 months: 5 sales ($8.1M).

Their filings also include shares returned to the company (5 filings), conversions (5 filings), grants and awards (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MLTX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.